Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Antimitogenic effects of HDL and APOE mediated by Cox-2–dependent IP activation
Devashish Kothapalli, … , Daniel J. Rader, Richard K. Assoian
Devashish Kothapalli, … , Daniel J. Rader, Richard K. Assoian
Published February 15, 2004
Citation Information: J Clin Invest. 2004;113(4):609-618. https://doi.org/10.1172/JCI19097.
View: Text | PDF
Article Cardiology

Antimitogenic effects of HDL and APOE mediated by Cox-2–dependent IP activation

  • Text
  • PDF
Abstract

HDL and its associated apo, APOE, inhibit S-phase entry of murine aortic smooth muscle cells. We report here that the antimitogenic effect of APOE maps to the N-terminal receptor–binding domain, that APOE and its N-terminal domain inhibit activation of the cyclin A promoter, and that these effects involve both pocket protein–dependent and independent pathways. These antimitogenic effects closely resemble those seen in response to activation of the prostacyclin receptor IP. Indeed, we found that HDL and APOE suppress aortic smooth muscle cell cycle progression by stimulating Cox-2 expression, leading to prostacyclin synthesis and an IP-dependent inhibition of the cyclin A gene. Similar results were detected in human aortic smooth muscle cells and in vivo using mice overexpressing APOE. Our results identify the Cox-2 gene as a target of APOE signaling, link HDL and APOE to IP action, and describe a potential new basis for the cardioprotective effect of HDL and APOE.

Authors

Devashish Kothapalli, Ilia Fuki, Kamilah Ali, Sheryl A. Stewart, Liang Zhao, Ron Yahil, David Kwiatkowski, Elizabeth A. Hawthorne, Garret A. FitzGerald, Michael C. Phillips, Sissel Lund-Katz, Ellen Puré, Daniel J. Rader, Richard K. Assoian

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
HDL and APOE inhibit S-phase entry in aortic SMCs. (a) Quiescent aortic ...
HDL and APOE inhibit S-phase entry in aortic SMCs. (a) Quiescent aortic SMCs were trypsinized and replated with 10% FBS for selected times in the absence (control) or presence of 50 μg/ml LDL, HDL, or APOE-depleted HDL. (b) Quiescent cells were stimulated with 10% FBS for 48 hours in the presence of increasing concentrations of LDL, HDL, or APOE-deficient HDL. (c) Quiescent aortic SMCs were trypsinized, added to 35-mm dishes containing coverslips, and stimulated with 10% FBS for 48 hours in the presence of increasing concentrations of APOA-I, APOE, APOE22, or APOE10. BrdU incorporation into nuclei was determined by immunofluorescence microscopy. Results show the mean ± SEM, n = 3, *P < 0.01 as compared with cells treated with 10% FBS alone.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts